Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$205.14
$0.14(0.05%)
At close: 4:00 PM EST
$205.14
$0.14(0.05%)
Day’s Range― - ―
52-Week Range$163.11 - $415.00
Previous CloseN/A
Volume197.44K
Average Volume (3M)1.39M
Market Cap
$48.74B
Enterprise Value$52.50B
Total Cash (Recent Filing)$21.96B
Total Debt (Recent Filing)$13.99B
Price to Earnings (P/E)43.4
Beta0.83
Next Earnings
Jul 29, 2026EPS Estimate
7.25Next Dividend Ex-DateN/A
Dividend Yield1.38%
Share Statistics
EPS (TTM)9.38
Shares Outstanding120,061,500
10 Day Avg. Volume1,220,193
30 Day Avg. Volume1,389,788
Financial Highlights & Ratios
PEG Ratio-18.55
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue0.38
Enterprise Value/Gross Profit2.73
Enterprise Value/Ebitda18.41
Forecast
1Y Price Target
$334.63Price Target Upside63.12% Upside
Rating ConsensusHold
Number of Analyst Covering20
EPS Forecast (FY)8.86
Revenue Forecast (FY)$162.16B
Bulls Say, Bears Say
Bulls Say
Medicare Advantage & Membership GrowthHumana's durable revenue base is anchored in Medicare Advantage and expanding Medicaid membership. Growing membership increases predictable capitated payments, spreads fixed costs, and enlarges the risk pool, supporting long‑term revenue stability and bargaining leverage with providers and suppliers.
CenterWell Primary Care Expansion And M&AExpanding owned primary care and targeted M&A gives Humana greater control of care delivery and care coordination. Vertical integration supports value‑based contracts, lowers avoidable utilization over time, and provides durable levers to improve medical cost management and member outcomes.
Improved Liquidity & Contingent Funding StructuresPre‑capitalized trusts and recent junior subordinated notes materially enhance committed funding capacity. This structural liquidity reduces refinancing and put‑exercise risk, giving Humana durable capital flexibility to meet regulatory, reserve, or transaction needs without forcing distressed asset sales.
Bears Say
Compressed Profitability And Lower ROEMaterial margin compression reduces Humana's earnings cushion against cost shocks and limits reinvestment capacity. Lower ROE and sustained thin margins make profitability highly sensitive to medical cost trends and reserving, weakening long‑term earnings durability if trends persist.
Weak And Volatile Free Cash Flow ConversionSubstantially lower FCF conversion means less internal funding for dividends, M&A, and margin recovery programs. Volatile operating cash flow raises reliance on external funding and increases vulnerability to reserve or claims volatility, constraining strategic flexibility over the medium term.
Medical Cost Trend, Elevated Reserves & Potential Cash PutsPersistently higher medical cost trends and elevated IBNR amplify earnings and cash pressure; potential $1.0–$1.5B put obligations add contingent liquidity risk. Combined, these structural exposures increase the need for sustained pricing discipline and could force benefit or capital actions.
HUM FAQ
What was Humana’s price range in the past 12 months?
Humana lowest stock price was $163.11 and its highest was $415.00 in the past 12 months.
What is Humana’s market cap?
Humana’s market cap is $48.74B.
When is Humana’s upcoming earnings report date?
Humana’s upcoming earnings report date is Jul 29, 2026 which is in 14 days.
How were Humana’s earnings last quarter?
Humana released its earnings results on Apr 29, 2026. The company reported $10.31 earnings per share for the quarter, beating the consensus estimate of $10.245 by $0.065.
Is Humana overvalued?
According to Wall Street analysts Humana’s price is currently Undervalued.
Does Humana pay dividends?
Humana pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 1.38%. See more information on Humana dividends here
What is Humana’s EPS estimate?
Humana’s EPS estimate is 7.25.
How many shares outstanding does Humana have?
Humana has 120,061,500 shares outstanding.
What happened to Humana’s price movement after its last earnings report?
Humana reported an EPS of $10.31 in its last earnings report, beating expectations of $10.245. Following the earnings report the stock price went up 5.833%.
Which hedge fund is a major shareholder of Humana?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$334.63 (63.12% Upside)
$334.63 (63.12% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
78.54%
12-Months-Change
Fundamentals
Return on Equity
6.19%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Humana
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
HUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income

HUM Stock 12 Month Forecast
Average Price Target
$334.63
▲(63.12% Upside)
Technical Analysis
Ownership Overview
0.26% Insiders
36.00% Mutual Funds
0.09% Other Institutional Investors
37.24% Public Companies and
Individual Investors












